PresentationI would now like to hand the call over to Troy Wilson, CEO. Please go ahead.Thank you for standing by and welcome to Kura Oncology's FT Pre-clinical Program Review: Synergistic Combinations with Targeted Therapies. [Operator Instructions]Troy WilsonChairman, CEO & President Thank you very much, and welcome, everyone, to our Farnesyl Transferase preclinical program review. I'm Troy Wilson, Kura's President and CEO. And it's a pleasure to have all of you with us today. We could go to the next slid ...